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p38 MAPK signaling acts upstream of LIF-dependent
neuroprotection during photoreceptor degeneration
C Agca1, A Gubler1, G Traber1, C Beck1, C Imsand1, D Ail1,2, C Caprara1,3 and C Grimm*,1,2,3
In many blinding diseases of the retina, loss of function and thus severe visual impairment results from apoptotic cell death of
damaged photoreceptors. In an attempt to survive, injured photoreceptors generate survival signals to induce intercellular
protective mechanisms that eventually may rescue photoreceptors from entering an apoptotic death pathway. One such
endogenous survival pathway is controlled by leukemia inhibitory factor (LIF), which is produced by a subset of Muller glia cells
in response to photoreceptor injury. In the absence of LIF, survival components are not activated and photoreceptor
degeneration is accelerated. Although LIF is a crucial factor for photoreceptor survival, the detailed mechanism of its induction
in the retina has not been elucidated. Here, we show that administration of tumor necrosis factor-alpha (TNF) was sufficient to
fully upregulate Lif expression in Muller cells in vitro and the retina in vivo. Increased Lif expression depended on p38 mitogen-
activated protein kinase (MAPK) since inhibition of its activity abolished Lif expression in vitro and in vivo. Inhibition of p38
MAPK activity reduced the Lif expression also in the model of light-induced retinal degeneration and resulted in increased cell
death in the light-exposed retina. Thus, expression of Lif in the injured retina and activation of the endogenous survival pathway
involve signaling through p38 MAPK.
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Throughout our life span, cells have to be repaired or
regenerated in order to maintain tissue function. Whereas
this happens frequently in most parts of the body, the
regeneration capacity of the nervous system is generally very
limited in mammals, and the consequences of neuronal
disease or injury are mostly irreversible. Therefore, it is crucial
to rescue neurons from devastating insults, a task that
requires activation of endogenous neuroprotective systems.
In the retina, several pathways exist to support the survival of
neurons.1–7 Leukemia inhibitory factor (LIF) controls one of
these pathways and is one of the most important endogenous
factors for neuroprotection in the retina.1,2 Photoreceptor injury
or degeneration activates a subset of Muller glia cells to express
Lif, which controls a cascade of neuroprotective signaling
between photoreceptors and Muller cells.1,8 These signaling
events include activation of the Janus kinase/signal transducer
and activator of transcription (JAK/STAT) pathway,9–11 and
result in the upregulation of several genes important for
neuroprotection, including signal transducer and activator of
transcription-3 (Stat3), endothelin-2 (End2) and fibroblast
growth factor-2 (Fgf2), and for gliosis (glial fibrillary acidic
protein,Gfap).1,12 In the absence of LIF, none of these factors is
induced, and photoreceptor cell death is accelerated.1,12
Although downstream events of LIF signaling have been
studied in the retina,1,12–14 the signal that initiates Lif
expression has not been elucidated. One of the hypotheses
for the initiation of survival pathways is based on the
generation of reactive oxygen species (ROS) in stressed
photoreceptors.15–17 Subtoxic levels of ROS have been
shown to be neuroprotective for photoreceptors and ROS
may act as signaling molecules for survival pathways in the
retina.15–18 Another hypothesis especially with respect to the
involvement of Muller cells includes tumor necrosis factor-
alpha (TNF) signaling, as TNF has been recently shown to be
the key signaling molecule for Muller cell proliferation and
differentiation into a photoreceptor fate in the degenerating
zebrafish retina.19 However, its role during photoreceptor
degeneration in the mammalian retina has not been identified
in detail.
TNF was shown to regulate expression of several important
factors that mediate a proinflammatory response. Likewise,
TNF treatment upregulates several cytokines including Lif in
various cell types.20,21 The reported neuroprotective effect of
TNF is mostly attributed to nuclear factor kappa-light-chain-
enhancer of activated B cells (NFkB) activation and the
resulting differential regulation of gene expression.22–27
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However, divergent data exist and various reports attribute
TNF also a role in the promotion of neurodegeneration
(reviewed in detail22,23). Blocking TNF in a glaucoma model
of retinal ganglion cell (RGC) death, for example, had
beneficial effects on RGC survival.28–30 In contrast, increased
survival of RGCs after axotomy of the optic nerve required
elevated and not decreased TNF levels.31
In addition to NFkB, TNF has been shown to activate the
p38 mitogen-activated protein kinase (MAPK) pathway in a
variety of models, and a small number of genes have been
identified that are regulated through p38 MAPK after TNF
induction.27 However, similar to TNF, no consensus exists on
the anti- or pro-apoptotic effects of p38 MAPK activity in
neuronal tissues. Active p38 MAPK signaling has been shown
to contribute to RGC death after ischemia or optic nerve
axotomy.32,33 In contrast, recent findings suggest that p38
MAPK activity is important for RGC survival after ischemia/
reperfusion injury,34,35 and that active crosstalk between
NFkB and p38 MAPK pathways may be an important aspect
of this neuroprotection.35
To date, the effects of TNF and p38 MAPK on photo-
receptor protection and their possible role in the regulation of
neuroprotective factors in the retina have not been studied.
To gain insight into the mechanisms that regulate LIF-
mediated neuroprotection, we investigated the contributions
of TNF and p38 MAPK to Lif expression both in vitro and
in vivo, and tested the relevance of the findings in the model of
light-induced retinal degeneration (LIRD) in vivo. The results
show that p38 MAPK activity is neuroprotective and required
to upregulate expression of Lif in the injured retina.
Results
TNF upregulates Lif expression through p38 MAPK in
cultured Muller cells in vitro. Previously, it has been
shown that treatment with recombinant TNF induces
upregulation of Lif expression in fibroblasts and other
cells.20,21 Since LIF is crucial for endogenous neuroprotec-
tion in the retina and is expressed by a subset of Muller cells
upon photoreceptor injury, we tested whether Muller cells
upregulate Lif in response to TNF administration in vitro.
When cultured rat Muller cells (rMC-1)36 were treated with
TNF, Lif and Tnf were simultaneously upregulated 10.7- and
21-fold, respectively (Figure 1). This transcriptional response
was fast and reached its peak at 1 h before it gradually
decreased towards basal levels even though TNF was still
present in the culture medium. This suggests a transcrip-
tional induction by TNF followed by suppression of expres-
sion. The transient upregulation of Lif and Tnf in Muller cells
is consistent with results from previously studied models.20,21
We also tested expression of genes that are known to be
upregulated in activated Muller cells including Gfap, ciliary
neurotrophic factor (Cntf) and Fgf2.1 However, none of these
genes was activated by TNF demonstrating a specificity of
TNF for the regulation of Lif expression in rMC-1 (Figure 1).
Stimulation of cells with TNF has been previously shown to
induce p38 MAPK signaling. Thus, we determined the role of
p38 MAPK in the regulation of Lif expression. Since the
expression of Lif in cultured Muller cells was robust, we first
tested the effect of p38 MAPK activity on basal Lif expression
in the absence of TNF by using two specific chemical
inhibitors for p38 MAPK activity, SB239063 and
SB202190.37,38 Treatment with either SB compound down-
regulated Lif expression in a dose-dependent manner within
1 h of treatment and at a similar concentration range
(Figures 2a and b). As expected, inhibitor treatment did not
block phosphorylation of p38 MAPK (see also Figures 5b and
c) but prevented its activity reducing activation of downstream
targets like heat shock protein-27 (data not shown). The effect
of p38 MAPK inhibition was specific for Lif as the expression of
Gfap, Cntf and Fgf2 was not reduced (Figures 2a and b).
To analyze whether TNF-mediated upregulation of Lif
expression also involves p38 MAPK signaling, we co-treated
Muller cells with TNF and SB239063. Consistent with our
results above (Figure 1), TNF treatment induced Lif expres-
sion (Figure 3a). However, inhibition of p38 MAPK activity by
SB239063 completely blocked Lif upregulation in the
presence of TNF (Figure 3a), suggesting that p38 MAPK
activity is crucial not only for basal Lif expression but also for
TNF-induced Lif upregulation.
Another signaling pathway known to be activated by TNF
centers around NFkB. Since multiple potential binding sites
for NFkB are located in the Lif promoter region (not shown)
and NFkB was identified to bind the Lif promoter upon
stimulation of cells with Toll-like receptor-2 (TLR2) agonists,39
we determined the activation of NFkB in Muller cells upon TNF
treatment using a luciferase reporter vector that contains
NFkB binding elements. Treatment with TNF strongly
increased luciferase levels suggesting that NFkB was
activated in Muller cells under these conditions (Figure 3b).
Importantly, addition of the p38 MAPK inhibitor SB202190
Figure 1 TNF treatment transiently upregulates Lif expression in Muller cells
in vitro. Real-time PCR analysis of gene expression in rMC-1 cells before (0 h) or at
various timepoints during TNF treatment as indicated. TNF (10 ng/ml) treatment
resulted in a strong upregulation of Lif expression as early as 30min. Peak of
expression was at 1 h. Tnf expression was upregulated similarly to Lif. In contrast,
expression of Cntf, Gfap and Fgf2 was not affected by TNF. Shown are
means±S.E.M. of N¼ 3. ANOVA with Dunnett’s post-tests was used to compare
control levels (at ‘0’) with expression levels of each gene at all timepoints after TNF
treatment. Note that the color of the stars indicating significance match the color of
the respective gene. *Po0.05
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completely inhibited TNF-induced Lif upregulation
(Figure 3a), but reduced TNF-induced NFkB activity only by
49% leaving it still fivefold above control levels (Figure 3b).
This indicates that, although p38 MAPK and NFkB pathways
may interact, increased NFkB activity may not be sufficient to
induce Lif expression in Muller cells in response to TNF
treatment (Figure 3b) in vitro.
Regulation of Lif expression in the neuronal retina
in vivo. Our results show that TNF induces Lif expression
via the p38 MAPK pathway in Muller cells in vitro.
To determine whether Lif expression is similarly regulated
in the healthy or injured neuronal retina in vivo, we injected
TNF, a water-soluble p38 MAPK inhibitor (SB220025
trihydrochloride),40 or a combination of both into the vitreous
of wild-type mice that were or were not exposed to damaging
levels of white light (Figures 4–7).
Similar to our observations in cultured Muller cells, TNF
injections increased the expression of Lif and Tnf in the retina
within 1 2 h before levels gradually decreased again
(Figure 4). Since Fgf2, End2 and Stat3 are part of the LIF-
controlled endogenous neuroprotective signaling system,1,12
we also analyzed their expression pattern after TNF
injections. Expression of all three genes was significantly
upregulated and peaked at around 12 h after injection and
thus with a slight delay compared with Lif (Figure 4). Although
not directly tested, this suggests that LIF may also be
important for Fgf2, End2 and Stat3 expression after TNF
injections, as it is in the injured retina.1,12 Similarly, expression
of Gfap, which has also been shown to depend on LIF
signaling,1 was upregulated with a similar delay (Figure 4).
In contrast, expression of paired box protein-6 (Pax6),
Lif receptor (Lifr) and Cntf, genes that may not depend on
LIF signaling, was not comparably regulated. Although CNTF
Figure 2 Inhibition of p38 MAPK activity downregulates Lif expression in Muller cells in vitro. Real-time PCR analysis of gene expression in rMC-1 cells before (control) or
at 1 h of treatment with various concentrations (as indicated) of p38 MAPK inhibitors SB239063 (a) or SB202190 (b). Expression levels of Lif inversely correlated with the
concentration of p38 MAPK inhibitors. Expression levels of Cntf, Gfap and Fgf2 were not affected. Shown are means±S.E.M. of N¼ 3. ANOVA with Dunnett’s post-tests was
used to compare control levels with expression levels of each gene after inhibitor treatment. Note that the color of the stars indicating significance match the color of the
respective gene. *Po0.05; **Po0.01; ***Po0.005
Figure 3 Inhibition of p38 MAPK activity prevents TNF-induced upregulation of Lif expression in Muller cells in vitro. (a) RT PCR analysis of Lif expression in rMC-1 cells
before (control, black bar) or at 1 h of treatment with TNF (10 ng/ml, blue bar), p38 MAPK inhibitor SB239063 (SB, 100mM, pink bar) or a combination of both (green bar).
Inhibition of p38 MAPK activity downregulated basal Lif expression and blocked TNF-induced Lif upregulation. Shown are means±S.E.M. of N¼ 3. ANOVA with Dunnett’s
post-tests was used to compare Lif levels after TNF injection with control levels or levels after SB or SBþ TNF treatment. (b) Luciferase levels in rMC-1 cells transfected with a
control vector or an NFkB reporter vector. Cells were treated for 6 h with TNF (10 ng/ml, blue bars), p38 MAPK inhibitor SB202190 (SB, 100mM, pink bars), or a combination of
both (green bars). Controls (black bars) were not treated. NFkB-mediated luciferase expression was upregulated by TNF treatment. The TNF-mediated upregulation was
partially blocked by the inhibitor of p38 MAPK activity. ANOVA with Dunnett’s post-tests was used to compare luciferase levels after TNF injection with levels of other
treatments. Statistics were calculated seperately for the ‘control vector’ group and the ‘NFkB vector’ group. Shown are means±S.E.M. of N¼ 4
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is strongly neuroprotective in the retina2,3 and belongs to the
same interleukin-6 (IL-6) family of cytokines as LIF, con-
sequences of TNF injections were thus rather specific for the
Lif gene.
To determine whether p38 MAPK is also involved in TNF-
induced Lif expression in the retina in vivo, we analyzed gene
expression at 2 and 6 h after intravitreal injection of TNF
and/or the p38 MAPK inhibitor SB220025. As expected,
injection of TNF caused increased Lif RNA levels at
both timepoints (Figure 5a). However, when SB220025 was
co-injected with TNF, upregulation of Lif expression was
reduced by 78 and 73% at the 2 and 6 h timepoints,
respectively. Injection of vehicle or SB220025 alone slightly
upregulated Lif expression probably due to injection-inflicted
retinal injury (Figure 5a). Western blots of retinal extracts
showed an approximately 7.5-fold increase in phosphoryla-
tion levels of p38 MAPK at 2 h after TNF injection as compared
with controls, suggesting that TNF increases p38 MAPK
activity in the retina (Figures 5b and c). Injection of the p38
MAPK inhibitor (which does not block phosphorylation but the
activity of p38 MAPK)40 either alone or in combination with
TNF also resulted in increased p38 phosphorylation levels
which may suggest an attempt of inhibitor-treated retinal cells
to increase p38 MAPK activity by a positive feedback. Since
vehicle injections upregulated phospho-p38 MAPK levels by
3.5-fold, intravitreal injections per se may generate a stress
response and activate p38 MAPK to a certain degree (Figures
5b and c). In summary, these data imply that the p38 MAPK
pathway is also important for TNF-mediated Lif regulation in
the neuronal retina in vivo.
p38 MAPK is an important regulator for increased Lif
expression after exposure to damaging light in vivo. We
showed that TNF-induced Lif upregulation depends on p38
MAPK activity in the healthy wild-type retina. To test whether
Lif regulation depends on p38 MAPK also in a disease
model, we exposed dark-adapted mice to high-intensity white
light that has been shown to cause photoreceptor degenera-
tion and to upregulate Lif expression in Muller cells.1 Six
hours after light exposure, Lif levels were increased 62-fold
Figure 4 Intravitreal injection of TNF induces Lif gene expression in the neuronal retina in vivo. Real-time PCR analysis of gene expression in retinas of C67BL/6 mice
before (control) or at indicated timepoints after intravitreal injection of TNF (blue lines) or vehicle (maroon lines). Lif and Tnf were upregulated as early as 1 h (Tnf) or 2 h (Lif)
after injection, before levels of Stat3, Edn2, Fgf2 andGfap started to increase at 6 h. Expression of Cntf, Lifr and Pax6was not remarkably affected by the injections. Shown are
means±S.E.M. of N¼ 3 4 per timepoint and treatment. Two-way ANOVA with Bonferroni post-test was used to test for statistical significance between treatments at each
timepoint. *Po0.05; ***Po0.005; ****Po0.001
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(Figure 6). Intravitreal injection of vehicle immediately after
light exposure slightly further increased Lif levels. Impor-
tantly, however, injection of p38 MAPK inhibitor SB220025
reduced Lif levels by 57% compared with vehicle injections.
Similarly to observations made before (Figure 5a), vehicle
injection induced Lif expression also in non-exposed mice
(dark controls). As in the light-exposed retinas, injection of
SB220025 reduced this induction by about 63% (Figure 6).
SB-mediated inhibition of Lif expression in the light-
exposed retina was not as strong as in TNFþSB-injected
retinas (Figure 5a), most probably because the SB inhibitor
was injected for experimental reasons 2 h after the start of light
exposure and thus only after the Lif-inducing signaling
cascade had been activated by the light stimulus. Cardio-
trophin-like cytokine (Clc) is another member of the IL-6 family
of cytokines that is upregulated in response to light damage.12
Similarly to Lif, induction of Clc was partially inhibited by SB
treatment (Figure 6). Analysis of Cntf, Gfap and vimentin
(Vim), which are expressed in Muller cells,41–43 did not show
any significant changes as a result of SB treatment (Figure 6).
These results imply that p38 MAPK is involved in controlling
Lif upregulation after light-induced photoreceptor injury
in vivo.
p38 MAPK activity is neuroprotective in the model of
light-induced photoreceptor degeneration. If p38 MAPK
is indeed important for regulation of neuroprotective Lif in the
injured retina, inhibition of its activity should increase
photoreceptor damage after light exposure. To directly test
this hypothesis, we quantified cell death in the retina at 40 h
after exposure of wild-type mice to high levels of white light.
Although intravitreal injections had a protective effect in
general (vehicle), inhibition of p38 MAPK by SB220025
significantly increased cell death as compared with vehicle
injections (compare ‘SB’ to ‘vehicle’). In contrast, TNF
injections reduced cell death almost to dark control levels
(Figure 7). Importantly, cell death showed a distinct negative
correlation with levels of Lif mRNA after no, SB, vehicle
or TNF injections (Figures 5a and 7), corroborating
earlier findings that showed that dosage and timing of Lif
expression is an important factor for retinal physiology and
neuroprotection.13,44,45 These results strongly argue that
LIF-mediated endogenous neuroprotection after light
damage depends on p38 MAPK signaling in the retina.
Discussion
Regulation of Lif expression in Muller cells. Our results
demonstrate that p38 MAPK signaling is required for the
regulation of Lif expression in Muller cells in vitro and in the
retina in vivo. We also show that inhibition of p38 MAPK
activity reduces Lif expression and increases cell death in a
model of photoreceptor injury supporting a direct role for p38
MAPK in LIF-mediated neuroprotection in the retina.
Furthermore, treatment with recombinant TNF was sufficient
to activate p38 MAPK, to increase Lif expression in vitro and
in vivo, and to protect against light damage in vivo. However,
whether endogenous TNF is involved in regulating Lif
expression in the injured retina in vivo needs still to be
determined, even though Tnf expression is induced early
after light exposure in the eyecup.46
p38 MAPK activity has been shown to be one of the most
important stress response factors by regulating the expres-
sion of several genes through activation of transcription
factors such as ATF2, CHOP, CREB and ELK1.22
Additionally, p38 MAPK affects gene expression at the
Figure 5 Activation of p38 MAPK is essential for TNF-induced upregulation of Lif expression in the neuronal retina in vivo. (a) RT PCR analysis of gene expression in
retinas of C67BL/6 mice before (no injection, black bars) or at 2 and 6 h after intravitreal injection of TNF (blue bars), p38 MAPK inhibitor SB220025 (SB, pink bar), TNFþ p38
MAPK inhibitor SB220025 (TNFþSB, green bar) or vehicle (maroon bar). TNF-mediated upregulation of Lif expression was significantly attenuated by the p38 MAPK
inhibitor. Shown are means±S.E.M. of N¼ 3 4 per timepoint and treatment. ANOVA with Bonferroni post-tests was used to compare expression levels after TNF injection
with levels of remaining groups at the 2-h timepoint. Student’s t-test was used to compare expression at 6 h. *Po0.05; **Po0.01; ***Po0.005. (b) Detection of phospho-p38
MAPK (upper panel) and p38 MAPK (lower panel) by western blot of protein extracts from retinas before (control) or at 2 h after injection of vehicle, TNF, p38 MAPK inhibitor
SB220025 (SB), or TNFþ p38 MAPK inhibitor SB220025 (TNFþSB) as indicated. Injection of TNF, SB and TNFþSB increased levels of phospho-p38 MAPK compared
with vehicle and uninjected retinas. Shown are representative blots. (c) Quantification of signals detected by western blot in (b) using Bio1D software. Phospho-p38 MAPK
levels were highest after injection of TNF, of p38 MAPK inhibitor SB220025 (SB) and of TNFþ p38 MAPK inhibitor SB220025 (TNFþ SB). Shown are means±S.E.M. of
N¼ 3–9 per treatment. ANOVA with Bonferroni post-tests was used to compare levels to control. *Po0.05
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post-transcriptional level by enhancing the stability of target
mRNAs containing AU-rich elements in their 30 UTRs.47 In our
experimental systems, however, we focused on the effects of
p38 MAPK signaling on the regulation of Lif expression at the
transcriptional level in vitro and in vivo.
Activation (phosphorylation) of p38 MAPK by TNF was
rapid, as was upregulation of Lif expression. The fast
upregulation of Lif levels was blocked by an inhibitor of p38
MAPK activity, suggesting that the initial role of p38 MAPK
involves transcriptional activation of Lif expression. Transcrip-
tion factors involved in this regulatory pathway have not been
defined and their identification will need further investigations.
However, NFkB is a candidate factor that was upregulated by
TNF treatment in a p38 MAPK-dependent manner (Figure 3),
and NFkB binding to the Lif promoter has recently been shown
in response to TLR2 agonists.39 Furthermore, a connection
between p38 MAPK, NFkB and cytokine regulation has been
suggested48 and TNF-mediated activation of p38 MAPK is
well documented.22 Nevertheless, the contribution of NFkB to
TNF-mediated Lif upregulation may not be major, or else may
depend on p38 MAPK. In the presence of TNF and the p38
MAPK inhibitor SB202190, Mu¨ller cells retain 50% of NFkB
activity but completely lack Lif upregulation (Figures 3a and b),
at least in vitro.
Regulation of Lif expression may additionally include a
second level of complexity. The fast increase in expression
Figure 6 p38 MAPK is involved in light-induced Lif upregulation in vivo. Real-time PCR analysis of retinal gene expression before (dark controls) or at 6 h after exposure to
2 h of 13 000 lux of white light. Vehicle (maroon bars) or p38 MAPK inhibitor SB220025 (SB, pink bars) was injected into the vitreous immediately after the end of light
exposure. Injections in dark-exposed control mice were done at a similar timepoint during the day to control for potential circadian alterations in gene expression. Light
exposure significantly upregulated Lif expression in non-injected (black bars) and vehicle-injected eyes. Upregulation was prevented by SB injections. Note that Lif levels in
light-exposed mice after SB injections were not different from dark control mice after vehicle injections. Expression of Clc was regulated similarly to Lif. Levels of Cntf, Vim and
Gfap were not affected by light exposure or injections. Shown are means±S.E.M. of N¼ 3–7 per treatment. ANOVA with Bonferroni post-tests was used to compare levels
after vehicle injection to levels after SB injections and to levels of mice that received no injection. Statistics were calculated seperately for the light-exposed groups and the
control groups. **Po0.01; ***Po0.005
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after TNF treatment in vitro (Figure 1) or after light exposure
in vivo,11 was followed by a rapid decline of Lif mRNA levels
towards basal levels. This argues for the presence of a
regulatory feedback loop and that transcriptional activation of
Lif expression might be followed by transcriptional inhibition or
by a reduction of Lif mRNA stability, or both.
Neuroprotective role of p38 MAPK activity and Lif
expression. Depending on the concept and experimental
setup, activation of p38 MAPK has been shown to promote
cell survival or apoptosis. Whereas inhibition of p38 MAPK
activity has been reported to protect 661W photoreceptor
cells against light damage in vitro,49 our results indicate that
inhibition of p38 MAPK activity accelerates light damage
in vivo. This discrepancy may be due to the lack of
intercellular communication between photoreceptors, RPE
and Muller cells in the in vitro cell culture system.
Photoreceptor degeneration induced in vivo by high levels
of white light depends on RPE65 in the RPE and on the
regeneration kinetics of the bleached chromophore in the
visual cycle.50,51 Hence mechanisms of light-induced death
in isolated 661W cells in vitro and photoreceptors in vivo
differ and the two experimental systems cannot be directly
compared. Of additional importance, photoreceptors injured
by light or other stimuli signal to Muller cells, which induce
expression of Lif to ignite a neuroprotective response in the
retina leading to increased photoreceptor survival.1,8 This
intercellular communication is not possible in the cell culture
system, and effects of p38 MAPK inhibition in 661W cells
may thus not accurately reflect the in vivo situation where
p38 MAPK activity seems important in Muller cells to
upregulate expression of neuroprotective Lif.
Despite the neuroprotective role of p38 MAPK, inhibition of
its activity in the presence of TNF was still protective against
LIRD, in contrast to inhibitor injections alone (Figure 7).
Protection correlated with increased levels of Lif in retinas of
eyes injected with a combination of TNF and inhibitor, and with
decreased Lif levels after injection of the p38 MAPK inhibitor
alone (Figure 5a). This suggests that injection of the p38 MAPK
inhibitor was not sufficient to completely block the strong Lif-
inducing activity of TNF and raises the possibility that a
mechanism for TNF-induced Lif upregulation in addition to p38
MAPK may be present in vivo. Alternatively, TNF may
potentially have protective effects through other mechanisms
such as NFkB activation and its downstream targets, or the
regulation of heat shock proteins.52 It is interesting to note that
p38 MAPK inhibitors only partially blocked TNF-induced NFkB
activation whereas they completely abolished Lif induction, at
least in vitro (Figure 5). This may argue that TNF could regulate
the fate of photoreceptor cells via several mechanisms.
Due to the inhibition of pro-inflammatory gene expression,
inhibitors of p38 MAPK are discussed as potential therapeutic
agents in inflammatory diseases like psoriasis and rheuma-
toid arthriis.53 Moreover, p38 MAPK inhibitors were shown to
block tumor growth and metastases formation.54 However,
our results demonstrating that inhibition of p38 MAPK activity
may be detrimental to injured photoreceptor cells ask for
precautions when developing p38 MAPK inhibitors for
therapeutic use. In cases of open or hidden retinal disease
conditions, application of p38 MAPK inhibitors to patients may
have adverse effects on vision due to its negative effect on Lif
expression and LIF-dependent survival factors in the retina.
Similar adverse effects may possibly be observed in other
neurodegenerative diseases where LIF has a reported
protective activity.55–57 Thus, as a safety measure, p38 MAPK
inhibitors may be designed not to cross retina blood or
brain blood barriers, which may prevent potential neuro-
degenerative effects.
Figure 7 Inhibition of p38 MAPK activity increases cell death in the retina after light exposure in vivo. Quantification of cell death in retinas of non-exposed SV129S6 mice
(dark controls) or in retinas of mice at 40 h after exposure to 2 h of 13 000 lux of white light (light damage). Twenty hours before light exposure, mice received an intravitreal
injection of TNF (blue bars), p38 MAPK inhibitor SB220025 (SB, pink bars), TNFþ p38 MAPK inhibitor SB220025 (TNFþ SB, green bars) or vehicle (maroon bars).
No-injection controls (black bars) were treated equally but did not receive intravitreal injections. The highest level of retinal cell death after light exposure was observed in non
injected mice. Vehicle injections induced a protection, which was further strengthened by injection of TNF. p38 MAPK inhibitor SB220025 increased cell death almost to
the level of non-injected control mice. Shown are means±S.E.M. of N¼ 3–7 per treatment. ANOVA with Bonferroni post-tests was used to compare levels of cell death of the
various groups to vehicle control. Statistics were calculated seperately for the light damage and the dark control group. *Po0.05; ***Po0.005
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TNF signaling in the retina. Although most reports attribute
TNF a devastating role in the retina and retinal diseases
through the modulation of an inflammatory response,28,29 our
results demonstrate that intravitreal injection of TNF before
light exposure did not accelerate degeneration. Rather, TNF
reduced the relative average cell death by almost fourfold
(0.27±0.049 S.E.M., N¼ 6 for vehicle versus 0.074±0.07
S.E.M. for TNF, N¼ 5). Even though these values did not
reach statistical significance when tested in context of the
additional experimental paradigms using analysis of variance
(ANOVA), they showed a tendency for TNF-mediated
protection of photoreceptors against light-induced degenera-
tion (Figure 7). At least part of this effect may be explained by
increased expression of Lif which leads to the upregulation
of neuroprotective factors like Fgf2, End2 and Stat3
(Figure 4).1,12
Emerging evidence indicates that TNF may be a signaling
molecule of general importance that has differential effects on
disease outcome depending on the interaction with its
receptors. In a retinal ischemia-reperfusion model, TNF-R2
signaling was neuroprotective whereas TNF-R1 increased
neuronal death.58 Moreover, a recent report suggests that
TNF expression in dying photoreceptors and Muller cells is
important for Muller cell proliferation and photoreceptor
regeneration in a zebrafish model of LIRD.19,59 Although the
mammalian retina diverges from zebrafish in several ways
including its limited proliferation and regeneration capacity of
Muller cells,60,61 these results together with our findings may
nevertheless indicate a possible role of TNF for the protection
of function in the stressed or injured mammalian retina.
Clearly, further studies are warranted to elucidate the role of
TNF signaling during photoreceptor degeneration in detail.
Materials and Methods
Animals. All experimental protocols were accepted by the Veterinary
Authorities of Zurich and experiments were conducted in accordance with the
statement of ‘The Association for Research in Vision and Ophthalmology’ for the
use of animals in research. All mice had access to food and water ad libitum and
were housed in a light–dark cycle of 12 : 12 h with 60 lux at cage level.
All experimental conditions and time points were tested with a minimum of N¼ 3
mice. All experimental mice were on a C57BL/6 background except for the light
damage experiments in which mice of the SV129/S6 strain were used (Figure 7).
For intravitreal injections after light exposure Rlbp::GFP mice62 on a C57BL/6
background were used (Figure 6).
Cell culture assays
TNF and p38 MAPK inhibitor treatment: rMC-1 cells36 were cultured in
Dulbecco’s modified Eagle’s medium (Life Technologies, Grand Island, NY, USA)
supplemented with 10% fetal bovine serum (Life Technologies), 100 U/ml penicillin
and 100mg/ml streptomycin (Life Technologies), and grown in a humidified 5%
CO2 incubator as described in Sarthy et al.
36 Rat recombinant TNF (R&D
Systems, Minneapolis, MN, USA) was dissolved in PBS containing 0.1% bovine
serum albumin (BSA) (Sigma Aldrich, St Louis, MO, USA), the p38 MAPK
inhibitors SB202190 and SB239063 (Sigma Aldrich) were dissolved in water or in
DMSO (Sigma Aldrich), respectively. Compounds were added alone or in
combinations directly to growth media at concentrations and times indicated in the
Results section.
Luciferase assay: rMC-1 cells were transfected using FuGENE6 reagent
(Promega, Madison, WI, USA). Renilla luciferase expressing vector, pRL-CMV
(Promega), was used as an internal control to normalize the transfection efficiency.
Transfection solution was prepared in 91 ml Optimem (Life Technologies) media
using 3mg/ml of total plasmid DNA and 9ml of FuGENE6 reagent according to
manufacturer’s instructions. The ratio of renilla to firefly plasmids was 1 : 9.
Ten thousand cells in 100ml growth media were seeded on a 96-well plate and
each well was transfected with 3.3ml of transfection solution after attachment.
An EGFP reporter vector, EGFP-C1 (Clontech, Mountain View, CA, USA), was
used to assess the transfection efficiency of rMC-1 cells, which was between 15
and 20%. Cells were transfected either with a control vector, pTAL-luc (Clontech),
or with an NFkB reporter vector, pNFkB-luc (Clontech). TNF, SB202190 and
TNFþ SB202190 treatments were performed for 6 h starting at 24 h after
transfection. TNF and SB202190 had final concentrations of 10 ng/ml and 100mM,
respectively. Each treatment was performed in triplicates in four independent
experiments. Luciferase levels were measured using the Dual Luciferase kit
(Promega).
Immunoblotting. Protein homogenates were prepared by sonication (Bran-
son sonifier, 10 strokes of 0.3 s with 30% output) of isolated retinas in Tris-HCl
(100mM, pH 7.5 or pH 8.0). Protein concentrations were determined by Bradford
using BSA as standard. Homogenates were mixed with an equal volume of 4X
Laemmli sample buffer and a total of 40mg/ml protein was loaded in each lane of
10% SDS-polyacrylamide gels. Samples were electrophoresed, blotted and
probed as described previously in Bu¨rgi et al.12 To detect phospho-p38 MAPK (cat
no. 840771; R&D Systems) and p38 MAPK (cat no. 9212; Cell Signaling, Danvers,
MA, USA) primary antibodies were used at a dilution of 1 : 500 and 1 : 1000,
respectively. The secondary antibody, anti-rabbit IgG peroxidase-linked (cat no.
NA934; GE Healthcare, Pittsburgh, PA, USA), was used at a dilution of 1 : 10 000.
We have used WesternBright Sirius HRP substrate (Advansta, Menlo Park, CA,
USA) for chemiluminescence reaction. Fusion FX7 Advance imaging system
(Vilber Lourmat, Torcy, France) with a CCD camera was used for digital signal
detection. Recordings were taken at the dynamic range of exposure without
binning. Calculations for exposure levels were performed using BioD1 software
(Vilber Lourmat) without background subtractions.
RT-PCR analysis. Retinas were collected through a slit in the cornea, and
total RNA was prepared and analyzed by real-time PCR (RT-PCR) as described
previously in Bu¨rgi et al.12 Briefly, 10 ng cDNA was amplified in a LightCycler
instrument (Roche Diagnostics, Basel, Switzerland) using appropriate primer pairs
(Table 1) and SybrGreen Master mix (Roche). Actb was used as reference gene.
For the analysis of gene expression in rMC-1 cells, total RNA was extracted using
the Megamax RNA isolation kit (Life Technologies) according to manufacturer’s
instructions. cDNA was prepared using the high-capacity cDNA reverse
transcription kit (Life Technologies). Real-time PCR reactions were conducted
using appropriate primer pairs (Table 1) and Actb as internal control. Additional
internal controls, Gapdh and Rpl32, were used for each new treatment. Real-time
PCR reactions were performed in a StepOne Real-Time PCR system with Fast
SybrGreen master mix (Life Technologies). The comparative cycle threshold
method was used to calculate relative transcript levels for both mouse and rat
experiments.
Intravitreal injections. Intravitreal injections were performed as previously
described in Joly et al.1 Rat recombinant TNF (R&D Systems) was reconstituted in
sterile PBS containing 0.1% BSA (Sigma Aldrich) and injected at a concentration of
10mg/ml. SB220025 trihydrochloride (Sigma Aldrich) was dissolved in water and
adjusted to 6mM using sterile PBS containing 0.1% BSA for injections. Sterile PBS
containing 0.1% BSA was used for vehicle control injections. For the injection of
TNFþSB220025, stock solutions for SB220025 and TNF were mixed and diluted
with PBS containing 0.1% BSA to reach final injection concentrations of 10mg/ml/ml
and 6mM for TNF and SB220025, respectively. Injection volume was 1ml.
Light damage and cell death assay. Light damage and quantification of
cell death by an ELISA-based cell death assay (Roche Diagnostics, Basel,
Switzerland) were performed essentially as previously described in Bu¨rgi et al.12
and Samardzjia et al.10 with minor modifications. White light intensity for light
damage was set to 13 000 lux, and 6–10-week-old animals with dilated pupils12
were exposed for 2 h. Animals were kept in darkness overnight before and after
light exposure. Animals were sacrificed and retinas were isolated for cell death
assay at 40 h after light exposure.
Data analysis. Statistical analysis was performed using ANOVA with
Dunnett’s Multiple Comparison tests where multiple comparisons were made to
a single value. ANOVA with Bonferroni post-test was performed for multiple
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comparisons against independent controls. Student’s t-tests were used for
individual pairwise comparisons. P-values lower than 0.05 were considered to be
significant. Error bars represent the standard error of the mean (S.E.M.). We also
used the ROUT algorithm, with the coefficient Q value of 0.1, to detect possible
outliers related to intravitreal injections. Graph Pad 6 software or Prism 5
(GraphPad Inc., San Diego, CA, USA) were used for all statistical analyses.
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